BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20220406T140000
DTEND;TZID=Europe/Brussels:20220406T151500
DTSTAMP:20220323T095447Z
CREATED:20220315T155237Z
LAST-MODIFIED:20220323T095447Z
UID:4186-1649253600-1649258100@www.europabio.org
SUMMARY:Rare Conversations: Game changing opportunities for the R&D community to address existing challenges in rare diseases
DESCRIPTION:Join the inaugural episode of the new Rare Conversations event series in 2022\, aimed at powering the next decade of rare disease innovation in Europe. \n\n\n\nThe first episode will be focused on game-changing opportunities for the R&D community to address existing challenges in rare diseases. The aim is to understand what is the basis needed to build the foundations for the future innovative rare disease ecosystem. \n\n\n\nThe event\, organized by Alexion\, AstraZeneca Rare Disease\, in cooperation with the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)\, will revolve around discussions on how the revision of the OMP Regulation can create a space for opportunities for scientific progress. \n\n\n\nBlock your calendar for 6th April from 14.00 – 15.15 CET. More information and the registration link will be shared with you shortly. \n\n\n\nAbout “Rare Conversations”Rare Conversations is an event series organized by Alexion to educate on rare diseases and facilitate multi-stakeholder exchange\, tackling timely topics of interest such as the revision of the OMP Regulation. Rare Conversations aims to unite and engage the rare disease community\, including key stakeholders in Brussels and EU Member States. Since its inception in December 2020\, four Rare Conversations have taken place\, each in cooperation with a different partner and focused on specific topics\, such as COVID and rare diseases\, the specificities of research in rare disease\, and EU and national value assessment for orphan drugs. People with rare diseases always stay at the centre of our activities and are part of every event.
URL:https://www.europabio.org/event/rare-conversations-2022/
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2022/03/Event-Banners-3-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20220422T140000
DTEND;TZID=Europe/Brussels:20220422T160000
DTSTAMP:20220420T132311Z
CREATED:20220420T130047Z
LAST-MODIFIED:20220420T132311Z
UID:4343-1650636000-1650643200@www.europabio.org
SUMMARY:ESAB Webinar:  Advances in the Analysis of Enzymatic Reactions and Finding New Enzymes
DESCRIPTION:Programme / Speakers        \n\n\n\n14:00 – 14:30: Droplet Microfluidics with Mass Spectrometry for High-Throughput Enzyme Reaction Analysis \n\n\n\nProf. Dr. Robert T. KennedyDepartment of Chemistry\, University of Michigan\, Ann Abor\, MI 48109\, USA \n\n\n\n14:30 – 15:00: Biomolecular engineeDroplets-on-demand platforms for the high-throughput characterisation of functional enzymes \n\n\n\nDr. Fabrice GielenDepartment of Physics\, Living Systems Institute\, University of Exeter\, UK \n\n\n\n15:00 – 15:30: Measuring Enzyme Kinetics\, Inhibition\, and Allostery using Isothermal Titration Calorimetry \n\n\n\nProf. Dr. Anthony K. MittermaierDepartment of Chemistry\, McGill University\, Montreal\, QC\, Canada  \n\n\n\n15:30 – 16:00: Redesign of oxidative enzymes for the biocatalytic valorisIdentification of diverse enzymes by screening biodiversity using innovative in silico approaches: example with the Amine Dehydrogenase family (MODAMDH Project)  \n\n\n\nDr. Carine Vergne-VaxelaireGénomique Métabolique UMR8030\, Genoscope\, CEA\, Univ Evry\, Université Paris-Saclay\, France \n\n\n\nFlyer \n\n\n\nAbstracts and Short Bios of the speakers \n\n\n\n\n\n\n\n\nREGISTER HERE
URL:https://www.europabio.org/event/esab-webinar-advances-in-the-analysis-of-enzymatic-reactions-and-finding-new-enzymes/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2022/04/fd-e1650460929130.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20220428T090000
DTEND;TZID=Europe/Brussels:20220428T180000
DTSTAMP:20220210T105735Z
CREATED:20220210T105733Z
LAST-MODIFIED:20220210T105735Z
UID:3929-1651136400-1651168800@www.europabio.org
SUMMARY:AseBio Investor Day 2022 | Madrid
DESCRIPTION:Spanish biotechnology makes up 2.8% of global production and is cited 30% more than the global average in this area. Spain is ranked 9th in scientific production in biotechnology and has the highest percentage of scientific papers in high-impact journals of any country: 83.3%. \n\n\n\nIn 2018\, the biotechnology sector invested nearly €770 million in R&D\, 71% from biotech companies. Biotech companies were ranked first in Spain in 2018 for R&D investment in industrial sectors\, surpassing the pharmaceutical sector for the first time. The year-on-year increase in R&D investment in 2018 was 13%\, among the five fastest-growing sectors in R&D investment in Spain. \n\n\n\nAseBio Investor Day is the leading event allowing Spanish innovative biotechnology projects to be introduced to an audience of leading international investors and pharmaceutical & industrial companies. \n\n\n\nThe event is organized by AseBio\, the Spanish Bioindustry Association. EuropaBio members are entitled to a discount (please liaise with Martina Cilia for more information: m.cilia@europabio.org).
URL:https://www.europabio.org/event/asebio-investor-day-2022-madrid/
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2022/02/Zoom-Banner-NAC-2022-600-×-200px-1-1.png
END:VEVENT
END:VCALENDAR